A detailed history of Charles Schwab Investment Management Inc transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 523,494 shares of AVNS stock, worth $8.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
523,494
Previous 568,228 7.87%
Holding current value
$8.39 Million
Previous $11.3 Million 11.13%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$19.21 - $24.69 $859,340 - $1.1 Million
-44,734 Reduced 7.87%
523,494 $12.6 Million
Q2 2024

Aug 12, 2024

SELL
$17.85 - $20.42 $801,197 - $916,551
-44,885 Reduced 7.32%
568,228 $11.3 Million
Q1 2024

May 08, 2024

BUY
$17.97 - $22.68 $897,763 - $1.13 Million
49,959 Added 8.87%
613,113 $12.2 Million
Q4 2023

Feb 06, 2024

SELL
$17.64 - $22.99 $128,560 - $167,551
-7,288 Reduced 1.28%
563,154 $12.6 Million
Q3 2023

Nov 08, 2023

BUY
$19.93 - $26.31 $694,062 - $916,245
34,825 Added 6.5%
570,442 $11.5 Million
Q2 2023

Aug 09, 2023

SELL
$22.53 - $30.98 $2.84 Million - $3.91 Million
-126,246 Reduced 19.07%
535,617 $13.7 Million
Q1 2023

May 11, 2023

SELL
$26.92 - $31.75 $158,908 - $187,420
-5,903 Reduced 0.88%
661,863 $19.7 Million
Q4 2022

Feb 13, 2023

BUY
$19.88 - $27.37 $331,996 - $457,079
16,700 Added 2.57%
667,766 $18.1 Million
Q3 2022

Nov 14, 2022

BUY
$21.56 - $29.59 $995,985 - $1.37 Million
46,196 Added 7.64%
651,066 $14.2 Million
Q2 2022

Aug 15, 2022

BUY
$24.87 - $34.68 $1.21 Million - $1.69 Million
48,842 Added 8.78%
604,870 $16.5 Million
Q1 2022

May 13, 2022

BUY
$28.87 - $35.77 $3.54 Million - $4.39 Million
122,601 Added 28.29%
556,028 $18.6 Million
Q4 2021

Feb 11, 2022

BUY
$29.25 - $36.02 $565,753 - $696,698
19,342 Added 4.67%
433,427 $15 Million
Q3 2021

Nov 16, 2021

BUY
$31.2 - $38.5 $229,070 - $282,667
7,342 Added 1.81%
414,085 $12.9 Million
Q2 2021

Aug 16, 2021

BUY
$36.37 - $45.72 $344,896 - $433,562
9,483 Added 2.39%
406,743 $14.8 Million
Q1 2021

May 17, 2021

BUY
$43.5 - $53.4 $158,166 - $194,162
3,636 Added 0.92%
397,260 $17.4 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $168,667 - $251,856
-5,088 Reduced 1.28%
393,624 $18.1 Million
Q3 2020

Nov 13, 2020

SELL
$28.67 - $34.32 $341,115 - $408,339
-11,898 Reduced 2.9%
398,712 $13.2 Million
Q2 2020

Aug 14, 2020

SELL
$23.48 - $33.86 $135,761 - $195,778
-5,782 Reduced 1.39%
410,610 $12.1 Million
Q1 2020

May 15, 2020

BUY
$20.64 - $34.41 $508,136 - $847,139
24,619 Added 6.28%
416,392 $11.2 Million
Q4 2019

Feb 07, 2020

BUY
$31.89 - $47.34 $144,493 - $214,497
4,531 Added 1.17%
391,773 $13.2 Million
Q3 2019

Nov 08, 2019

BUY
$32.06 - $44.0 $560,729 - $769,560
17,490 Added 4.73%
387,242 $14.5 Million
Q2 2019

Aug 09, 2019

SELL
$37.68 - $46.52 $88,736 - $109,554
-2,355 Reduced 0.63%
369,752 $16.1 Million
Q1 2019

May 14, 2019

BUY
$39.84 - $51.04 $261,868 - $335,485
6,573 Added 1.8%
372,107 $15.9 Million
Q4 2018

Feb 14, 2019

SELL
$41.16 - $66.67 $291,124 - $471,556
-7,073 Reduced 1.9%
365,534 $16.4 Million
Q3 2018

Nov 13, 2018

BUY
$55.13 - $72.65 $20.5 Million - $27.1 Million
372,607 New
372,607 $25.5 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.